Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance
Manal Rayyan, Adjunct Assistant Professor at United Arab Emirates University, Senior Clinical Pharmacist at SEHA Tawam Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:
“I’m pleased to share our latest publication:
‘Real-world treatment patterns and outcomes of switching to efanesoctocog alfa in children with haemophilia A: A single-centre experience from the UAE.’
Conducted at Tawam Hospital, this study shows excellent real-world outcomes after switching to once-weekly efanesoctocog alfa prophylaxis, with all patients achieving zero annualized bleeding rate (ABR) and demonstrating a strong safety profile.
I’m grateful to my co-authors and colleagues for their collaboration and commitment to improving care for children with bleeding disorders.
Congratulations to the entire team!”
Title: Real-world treatment patterns and outcomes of switching to efanesoctocog alfa in children with severe and moderate haemophilia a: A single-centre experience from the United Arab Emirates
Authors: Muhammad Faisal Khanani, Najam Awan, Haydar Alrufaey, Manal Ryan

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines